Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ryerson Holding Corporation | 7RY | Sep 20, 2024 | 18.10 | +4.02 |
RYMAN HEALTHC.UNSP.ADR/5 | RH70 | Sep 20, 2024 | 11.80 | -4.07 |
Ryman Healthcare | RH7 | Sep 20, 2024 | 2.42 | -2.81 |
Ryman Hospitality Properties, Inc. (REIT) | 4RH | Sep 20, 2024 | 97.00 | +3.74 |
Ryobi Limited | RYO1 | Sep 20, 2024 | 12.30 | +1.65 |
Ryohin Keikaku Co. Ltd. | 3RK | Sep 20, 2024 | 15.90 | 0.00 |
Ryohin Keikaku Co. Ltd. | 3RKU | Sep 20, 2024 | 16.10 | +1.26 |
Ryvu Therapeutics S.A. | 9Y4 | Sep 20, 2024 | 12.30 | -0.49 |
S & U plc | 97V | Sep 20, 2024 | 19.80 | -2.94 |
S IMMO AG | T1L | Sep 20, 2024 | 22.00 | -0.45 |
S&P Global Inc. | MHL | Sep 20, 2024 | 466.90 | -1.08 |
S&W Seed Company | 210 | Sep 20, 2024 | 0.20 | +15.38 |
S-Enjoy Service Group Co. Limited | 78E | Sep 20, 2024 | 0.23 | +3.64 |
S.D. Standard Drilling | S1P | Sep 20, 2024 | 0.15 | +1.10 |
S.M.A.I.O S.A. | G3O | Sep 20, 2024 | 3.85 | +0.26 |
S2Medical | S21 | Sep 20, 2024 | 0.00 | 0.00 |
S4 Capital PLC Shs (United Kingdom) | 9S4 | Sep 20, 2024 | 0.48 | -6.02 |
SA SA INTL | SSW | Sep 20, 2024 | 0.07 | -0.68 |
SAAB AB UNSP.ADR/0,5 | SDV0 | Sep 20, 2024 | 10.20 | +0.99 |
SAAB AB B O.N. | SDV1 | Sep 20, 2024 | 20.09 | -1.23 |
SAAB B | SDV | Sep 20, 2024 | 78.00 | 0.00 |
Saba Capital Income & Opportunities Fund | 14H0 | Sep 20, 2024 | 6.44 | +0.06 |
Sabien Technology Group Plc | SUJ0 | Sep 20, 2024 | 0.09 | +6.82 |
SABIO HOLDINGS INC. | 68J | Sep 20, 2024 | 0.28 | 0.00 |
SABLE RESOURCES LTD | 5XL | Sep 20, 2024 | 0.02 | +7.89 |
Sabra Health Care REIT, Inc. | SBC | Sep 20, 2024 | 16.34 | -4.31 |
Sabre Corporation | 19S | Sep 20, 2024 | 2.85 | -1.45 |
Sabre Insurance | 18M | Sep 20, 2024 | 1.75 | +1.74 |
Sabre Resources Ltd | SAL | Sep 20, 2024 | 0.01 | 0.00 |
SACCHERIA F.LLI FRANCES. | YV1 | Sep 20, 2024 | 1.05 | -0.94 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.